title: Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers.
abstract: Activating point mutations of RET gene have been demonstrated to be causative of the familial form of medullary thyroid cancer (MTC), both isolated (FMTC) and associated to other endocrine neoplasia [multiple endocrine neoplasia (MEN) 2A and 2B]. In RET gene mutation carriers, who are prone to developing MTC, prophylactic thyroidectomy is recommended to obtain their definitive cure. The simultaneous excision of the central node compartment is mandatory when the stimulation pentagastrin test for serum calcitonin is positive. Although the minimally invasive video assisted thyroidectomy (MIVAT) is nowadays currently adopted in many centers, it has never been employed for the prophylactic thyroidectomy of RET gene mutation carriers. The fear of obtaining an incomplete lymphadenectomy of the central compartment was the main reason for this reluctance. Since RET gene mutation carriers have often normal thyroid volume and, if involved, small lymph nodes, they indeed represent the best candidates to this approach especially when considering that they are usually young and concerned about the cosmetic results and the period of hospitalization. The excellent results obtained by MIVAT in the last few years induced us to propose this procedure together with a central compartment lymphadenectomy to 2 RET gene mutation carriers recently found by genetic screening. As assessed by a negative pentagastrin stimulation test performed after 6 months from the MIVAT, they were definitively cured without any surgical complication with the exception of a transient hypoparathyroidism. They showed a great satisfaction for both the cosmetic results and the very short period of hospitalization, thus supporting the idea that MIVAT can be used in association with the central node dissection for the prophylactic treatment of RET mutation gene carriers whose thyroid volume is still normal.
authors.affiliation: Department of Surgery, University of Pisa, Pisa, Italy. p.miccoli@dc.med.unipi.it
authors.forename: P
authors.initials: P
authors.lastname: Miccoli
authors.forename: R
authors.initials: R
authors.lastname: Elisei
authors.forename: P
authors.initials: P
authors.lastname: Berti
authors.forename: G
authors.initials: G
authors.lastname: Materazzi
authors.forename: L
authors.initials: L
authors.lastname: Agate
authors.forename: M G
authors.initials: MG
authors.lastname: Castagna
authors.forename: B
authors.initials: B
authors.lastname: Cosci
authors.forename: P
authors.initials: P
authors.lastname: Faviana
authors.forename: C
authors.initials: C
authors.lastname: Ugolini
authors.forename: A
authors.initials: A
authors.lastname: Pinchera
mesh_terms: D000328:Adult; D018276:Carcinoma, Medullary / Q000235:genetics* / Q000517:prevention & control*; D005260:Female; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D007011:Hypoparathyroidism; D008197:Lymph Node Excision / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015513:Oncogene Proteins / Q000235:genetics*; D017354:Point Mutation; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D035781:Siblings; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000517:prevention & control*; D013965:Thyroidectomy / Q000379:methods*; D020535:Video-Assisted Surgery / Q000379:methods*
chemical_list: D015513:Oncogene Proteins; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; D020794:Receptor Protein-Tyrosine Kinases
references.citation: Thyroid. 2001 Feb;11(2):161-3
references.pmid: 11288985
references.citation: Am J Surg. 2001 Jun;181(6):567-70
references.pmid: 11513788
references.citation: Surgery. 2002 Dec;132(6):1070-3; discussion 1073-4
references.pmid: 12490857
references.citation: J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71
references.pmid: 11739416
references.citation: Surgery. 1995 Dec;118(6):1099-103; discussion 1103-4
references.pmid: 7491529
references.citation: Nature. 1993 Jun 3;363(6428):458-60
references.pmid: 8099202
references.citation: Ann Surg. 1994 Sep;220(3):237-47; discussion 247-50
references.pmid: 7916559
references.citation: Surg Endosc. 2002 Dec;16(12 ):1741-5
references.pmid: 12140635
references.citation: Surgery. 2001 Dec;130(6):1039-43
references.pmid: 11742335
references.citation: J Endocrinol Invest. 1999 Dec;22(11):849-51
references.pmid: 10710272
references.citation: Oncogene. 1994 Oct;9(10):3025-9
references.pmid: 8084609
references.citation: J Clin Endocrinol Metab. 1994 Apr;78(4):826-9
references.pmid: 8157706
references.citation: World J Surg. 2002 Aug;26(8):972-5
references.pmid: 12016476
references.citation: World J Surg. 1998 Jul;22(7):744-50; discussion 750-1
references.pmid: 9606292
references.citation: Arch Surg. 2002 Mar;137(3):301-4; discussion 305
references.pmid: 11888453
references.citation: Surgery. 1995 Dec;118(6):1031-5
references.pmid: 7491519
references.citation: N Engl J Med. 1994 Sep 29;331(13):828-35
references.pmid: 7915822
references.citation: Hum Mol Genet. 1993 Jul;2(7):851-6
references.pmid: 8103403
references.citation: Ann Chir. 2000 Jun;125(5):468-72
references.pmid: 10925490
references.citation: Cancer. 2000 Apr 15;88(8):1909-15
references.pmid: 10760769
references.citation: J Clin Endocrinol Metab. 1997 Jan;82(1):39-41
references.pmid: 8989229
references.citation: J Clin Endocrinol Metab. 2004 Jan;89(1):163-8
references.pmid: 14715844
references.citation: J Am Coll Surg. 2000 Sep;191(3):336-40
references.pmid: 10989910